IL-25 regulates Th17 function in autoimmune inflammation
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Interleukin (IL)-25 is a member of the IL-17 family of cytokines. However, unlike the other members of this family, IL-25 promotes T helper (Th) 2 responses. We now show that IL-25 also regulates the development of autoimmune inflammation mediated by IL-17-producing T cells. We have generated IL-25-deficient (il25-/-) mice and found that they are highly susceptible to experimental autoimmune encephalomyelitis (EAE). The accelerated disease in the il25-/- mice is associated with an increase of IL-23 in the periphery and a subsequent increase in the number of inflammatory IL-17-, IFNgamma-, and TNF-producing T cells that invade the central nervous system. Neutralization of IL-17 but not IFNgamma in il25-/- mice prevented EAE, suggesting that IL-17 is a major disease-promoting factor. IL-25 treatment at several time points during a relapse-remitting model or chronic model of EAE completely suppressed disease. IL-25 treatment induced elevated production of IL-13, which is required for suppression of Th17 responses by direct inhibition of IL-23, IL-1beta, and IL-6 expression in activated dendritic cells. Thus, IL-25 and IL-17, being members of the same cytokine family, play opposing roles in the pathogenesis of organ-specific autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-25 can also inhibit autoimmunity mediated by Th17 cells.”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Kleinschek et al., 2007
In the citing paper
“IL-25 treatment elevated production of IL-13 and suppressed expression of IL-1, IL-6, and IL-23 by activated dendritic cells”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Kleinschek et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189 · cited 1×
“Consistent with pervious reports (55, 56), we observed that IL-25 could induce IL-13 mRNA expression in cultured DCs (unpublished data).”
ResultIvanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Self-citationHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742 · cited 3×
“Recent in vitro studies have suggested that Th17 cells are also negatively regulated by IL-4 signaling pathways (21, 22).”
BackgroundResultA distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 3×
“Recent in vitro studies have suggested that Th17 cells are also negatively regulated by IL-4 signaling pathways (21, 22).”
BackgroundResultIL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 3×
“In contrast, anti-IFNγ treatment had no eff ect, consistent with studies demonstrating that Th1 cells only play a minor role in EAE (13).”
BackgroundResultSelf-citationVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906 · cited 1×
“cyto metric sorting from >100 irradiation bone marrow chimeric mice (11).”
BackgroundSelf-citationInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“Although IL-25 promotes allergic responses, IL-17A had been characterized to promote chronic infl ammatory responses (9, 10).”
Background
Cited by
Items 201–300 of 399
Bradshaw, G., Lualhati, R. R., Albury, C. L., Maksemous, N., Roos-Araujo, D., Smith, R. A., Benton, M. C., Eccles, D., Lea, R. A., Sutherland, H. G. E., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00420 · Cited by 45
Wang, Q., Zheng, Y., Huang, Z., Tian, Y., Zhou, J., Mao, Q., Wu, Y., & Ni, B. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-25 · Cited by 39
“Several reports have shown evidence that Treg cells are involved in hepatitis B pathogenesis [6-10].”
BackgroundTargeting the Epithelium-Derived Innate Cytokines: From Bench to Bedside
Ham, J., Shin, J. W., Ko, B. C., & Kim, H. Y. (2022) · Immune Network · doi:10.4110/in.2022.22.e11 · Cited by 37
“1) and in fact are important in various inflammatory diseases that do not involve type-2 responses, including psoriasis, multiple sclerosis (MS), and cancer (4-10).”
BackgroundDas, U. N. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01173-8 · Cited by 39
Risk of Inflammatory Bowel Disease in Patients With Atopic Dermatitis
Fuxench, Z. C. C., Wan, J., Wang, S., Syed, M. N., Shin, D. B., Abuabara, K., & Gelfand, J. M. (2023) · JAMA Dermatology · doi:10.1001/jamadermatol.2023.2875 · Cited by 40
“Age, median (IQR), y 4 (2-9) 4 (1-8) 9 (4-14) 5 (1-10) 47 (32-64) 45 (30-63) 50 (34-68) 47 (32-63)”
Mankan, A. K., Canli, Ö., Schwitalla, S., Ziegler, P. K., Tschopp, J., Korn, T., & Greten, F. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018331108 · Cited by 41
“In particular, experimental autoimmune encephalomyelitis (EAE), the most widely used animal model of multiple sclerosis, is driven by a myelin antigen-specific Th17 response (17, 25) yet CNS-restricted ablation of NF-κB signaling ameliorates EAE severity (26).”
BackgroundZhang, J., Huang, Z., Sun, R., Tian, Z., & Wei, H. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.11.017 · Cited by 36
“In contrast, IFN-g, IL-25 and IL27 potently inhibit Th17 development [30].”
ResultReyes, J. L., Fernando, M. R., Lopes, F., Leung, G., Mancini, N. L., Matisz, C. E., Wang, A., & McKay, D. M. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005481 · Cited by 36
“In the context of TH1-mediated pathologies, IL-25 has been shown to suppress IL-17 and IFNγ production in infectious [26] and autoimmune diseases (e.g experimental autoimmune encephalitis (EAE) [59] and diabetes [45]).”
BackgroundXie, L., Gong, W., Chen, J., Xie, H., Wang, M., Yin, X., & Wu, W. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.06.022 · Cited by 38
PI3K inhibitors as potential therapeutics for autoimmune disease
Ball, J., Archer, S., & Ward, S. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.04.002 · Cited by 38
Paintlia, A. S., Paintlia, M. K., Singh, I., & Singh, A. K. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.07.024 · Cited by 35
“IFN-γ producing cells can induce EAE, and their presence within the CNS likely contributes to acute inflammation, whereas the IL-17 immune pathway is suggested to play an important role in the disease process (Kleinschek et al., 2007).”
InfluentialOleanolic acid ameliorates intestinal alterations associated with EAE
Gutiérrez, B., Gallardo, I., Ruíz, L., Álvarez, Y., Cachofeiro, V., Margollés, A., Hernández, M., & Nieto, M. L. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02042-6 · Cited by 37
VSTM1-v2, a novel soluble glycoprotein, promotes the differentiation and activation of Th17 cells
Guo, X., Zhang, Y., Wang, P., Li, T., Fu, W., Mo, X., Shi, T., Zhang, Z., Chen, Y., Ma, D., et al. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.07.009 · Cited by 35
Self-citationAirway responses towards allergens – from the airway epithelium to T cells
Papazian, D., Hansen, S., & Würtzen, P. A. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12451 · Cited by 38
Lavocat, F., Ndongo-Thiam, N., & Miossec, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00647 · Cited by 35
“IL-25 regulates Th17 function in autoimmune inflammation.”
BackgroundInfluentialDey, I., & Bishayi, B. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.10.033 · Cited by 37
Korn, T., Mitsdoerffer, M., & Kuchroo, V. K. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2008_17 · Cited by 45
Pappu, B. P., Angkasekwinai, P., & Dong, C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.12.003 · Cited by 38
Th17 cells: a third subset of CD4+ T effector cells involved in organ-specific autoimmunity
Kurts, C. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm800 · Cited by 45
Li, C., Zhao, Y., Zhang, W., & Zhang, W. (2011) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2010.11.032 · Cited by 34
Ma, H., Xu, J., Liu, X., Zhu, Y., Gao, B., Karin, M., Tsukamoto, H., Jeste, D. V., Grant, I., Roberts, A. J., et al. (2016) · Current Pathobiology Reports · doi:10.1007/s40139-016-0097-3 · Cited by 34
Kobayashi, S., Hara, A., Isagawa, T., Manabe, I., Takeda, K., & Maruyama, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110838 · Cited by 32
“Next, we generated classical Th17-dependent EAE models by immunizing mice with the MOG peptide [17,18].”
MethodAliyu, M., Zohora, F. T., Ceylan, A., Hossain, F., Yazdani, R., & Azizi, G. (2024) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2024.2330642 · Cited by 31
“Moreover, the il-25 −/− eAe mice had higher level of cNS th17 and iFN-γ producing t cells compared to the control [34].”
BackgroundJi, N., Sosa, R. A., & Forsthuber, T. G. (2011) · Immunotherapy · doi:10.2217/imt.10.111 · Cited by 34
Stacchiotti, C., di Regnella, S. M., Cinotti, M., Spalloni, A., & Volpe, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083854 · Cited by 35
“Recent studies have revealed that IL-25 treatment reduces neuroinflammation and EAE disease severity [37,139], suggesting that IL-25 and IL-17, despite being members of the same cytokine family, play opposing roles in the pathogenesis of MS. Similar findings have been observed in mouse models of…”
Pathogenesis-oriented therapy of psoriasis using biologics
Boehncke, W., & Brembilla, N. C. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2100219 · Cited by 32
“In mouse models, IL-17E attenuates collagen-induced arthritis (CIA) development, suppresses TH17 cell responses in EAE, and protects against atherosclerosis [54].”
BackgroundThe epithelial barrier and immunoglobulin A system in allergy
Carlier, F. M., Sibille, Y., & Pilette, C. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12830 · Cited by 30
Ishii, A., Oboki, K., Nambu, A., Morita, H., Ohno, T., Kajiwara, N., Arae, K., Sudo, H., Okumura, K., Saito, H., et al. (2010) · Allergology International · doi:10.2332/allergolint.10-oa-0218 · Cited by 32
Acute blockade of IL-25 in a colitis associated colon cancer model leads to increased tumor burden
Thelen, T. D., Green, R. M., & Ziegler, S. F. (2016) · Scientific Reports · doi:10.1038/srep25643 · Cited by 29
Guggino, G., Lin, X., Rizzo, A. G., Xiao, F., Saieva, L., Raimondo, S., Liberto, D. D., Candore, G., Ruscitti, P., Cipriani, P., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40500 · Cited by 26
“Conversely, IL25/IL-17RB interaction essentially regulates B cell function, induces autoimmune Th17-driven inflammation, and promotes Th2 responses by increasing the frequency of M2-polarized macrophages and the differentiation of ILC2s (6,7,9,21).”
BackgroundSalnikov, M. Y., Prusinkiewicz, M. A., Lin, S., Ghasemi, F., Cecchini, M. J., & Mymryk, J. S. (2023) · Viruses · doi:10.3390/v15010176 · Cited by 29
“More specifically, the immune response in EBVaGCs was shifted more towards a Th2 response and away from a Th17 one as compared to the EBVnGCs (Figure 3), which aligns with the competitive nature of the two responses [30].”
ResultNovel therapeutic targets along the Th17 pathway
Ouyang, W., Filvaroff, E. H., Hu, Y., & Grogan, J. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200839105 · Cited by 27
T‐helper 17 cell: A distinctive cell in liver diseases
Ye, C., Li, W., Zheng, M., & Chen, Y. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00744.x · Cited by 28
Self-citationIL‐25 exhibits disparate roles during Th2‐cell differentiation versus effector function
Mearns, H., Forbes‐Blom, E., Camberis, M., Tang, S., Kyle, R. L., Harvie, M., Kleinschek, M. A., & Gros, G. S. L. (2014) · European Journal of Immunology · doi:10.1002/eji.201344400 · Cited by 26
Self-citationRynda, A., Maddaloni, M., Ochoa‐Repáraz, J., Callis, G. M., & Pascual, D. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008720 · Cited by 25
“. Surprisingly, IL-4 deficiency has not been associated with increased susceptibility to autoimmune diseases, suggesting a supportive role for IL-4 in suppression of inflammatory responses against self-Ags”
Neuroimmune Modulation of Gut Function
Shea‐Donohue, T., & Urban, J. F. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_109 · Cited by 27
Marković, M., Miljković, D. M., Momčilović, M. B., Popadic, D. M., Miljković, Ž., Savić, E., Ramić, Z., & Stojković, M. M. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.01.012 · Cited by 24
T helper 17 cell-related cytokines in serum and saliva during management of periodontitis
Medara, N., Lenzo, J. C., Walsh, K. A., Darby, I. B., O’brien-simpson, N. M., & Reynolds, E. C. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155186 · Cited by 25
Wen, X., Song, G., Hu, C., Pan, J., Wu, Z., Li, L., Liu, C., Tian, X., Zhang, F., Qian, J. X., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002119 · Cited by 24
“On the other hand, IL-17E/IL-17RB interaction can promote Th2 responses, regulate B cell function, and induce Th17-driven autoimmune inflammation (25).”
BackgroundTLR9–IL-2 axis exacerbates allergic asthma by preventing IL-17A hyperproduction
Murakami, Y., Ishii, T., Nunokawa, H., Kurata, K., Narita, T., & Yamashita, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-75153-y · Cited by 24
Wang, A., Smith, A. D., Li, Y., Urban, J. F., Ramalingam, T. R., Wynn, T. A., Lü, N., Shea‐Donohue, T., Yang, Z., & Zhao, A. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-72 · Cited by 27
“Mice with IL-25 deficiency (IL-25) develop severe intestinal inflammation during nematode infection implicating a pivotal role of IL-25 in gut mucosal homeostasis [14,15].”
BackgroundWang, R., & Maksymowych, W. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715510 · Cited by 27
Targeting interleukin-17 as a novel treatment option for fibrotic diseases
Sisto, M., & Lisi, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010164 · Cited by 22
“Therefore, IL-17E induces expression of IL-4, IL-5, and IL-13, all of which are associated with type 2 immunity [46], and is able to promote epithelial-cell hyperplasia by increasing mucus secretion and hyperreactivity of the airway epithelium [47].”
Tomioka, H., Tatano, Y., Sano, C., & Shimizu, T. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0177-y · Cited by 23
“ber of the IL-17 family, is known to downregulate Th17 responses by elevating the production of IL-13, which is required for direct inhibition of IL-23, IL-1b, and IL-6 expression in activated dendritic cells [97].”
BackgroundEnvironmental control of Th17 differentiation
Quintana, F. J., & Weiner, H. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200839198 · Cited by 23
Szymańska-Kałuża, J., Cebula‐Obrzut, B., Smolewski, P., Stańczyk, J., & Smolewska, E. B. (2014) · Central European Journal of Immunology · doi:10.5114/ceji.2014.42128 · Cited by 22
Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia
Maiorino, C., Khorooshi, R., Ruffini, F., Løbner, M., Bergami, A., Garzetti, L., Martino, G., Owens, T., & Furlan, R. (2012) · Gene Therapy · doi:10.1038/gt.2012.58 · Cited by 22
Scanlon, S. T., & McKenzie, A. N. J. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12464 · Cited by 26
Les cellules Th17: Une nouvelle population de cellules T CD4 effectrices pro-inflammatoires
Leung–Theung–Long, S., & Guerder, S. (2008) · médecine/sciences · doi:10.1051/medsci/20082411972 · Cited by 24
Karimabad, M. N., Falahati‐pour, S. K., & Hassanshahi, G. (2016) · NeuroImmunoModulation · doi:10.1159/000449427 · Cited by 22
Proteomic analysis of sputum in patients with active pulmonary tuberculosis
Fu, Y., Yi, Z., Guan, S., Zhang, S. Y., & Li, M. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03824.x · Cited by 20
“Unlike the other members of this family, IL-25 promotes T helper (Th) 2 responses by driving the expression of IL-4, IL-5 and IL-13 [27].”
BackgroundThe Current Concept of T H 17 Cells and Their Expanding Role in Systemic Lupus Erythematosus
Perry, D. J., Peck, A. B., Carcamo, W. C., Morel, L. M., & Nguyen, C. Q. (2011) · Arthritis · doi:10.1155/2011/810649 · Cited by 22
“However, a recent study by Ishigame et al. [23] suggested that there are differential roles for IL-17A and IL-17F in autoimmune responses, in which IL-17F played a minimal role in the pathogenesis of delayed-type and contact hypersensitivities, EAE, CIA, and arthritis in animal models.”
BackgroundInfluentialEmerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis
Jou, E., Rodríguez‐Rodríguez, N., & McKenzie, A. N. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.981479 · Cited by 19
“Conversely, IL-25 has been shown to suppress both Th1 and Th17 immunity in inflammatory conditions (54, 55).”
BackgroundThe synapse revisited: Molecular networks of CD4 T cell–DC interactions
Bonilha, C. S. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115715 · Cited by 19
β-Lapachone ameliorization of experimental autoimmune encephalomyelitis
Xu, J., Wagoner, G., Douglas, J. C., & Drew, P. D. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.09.004 · Cited by 19
“Also, adoptive transfer of Th17 cells induces EAE (Kleinschek et al., 2007).”
BackgroundThe Role of TNFRSF25:TNFSF15 in Disease… and Health?
Schreiber, T. H., Wolf, D., & Podack, E. R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6612-4_30 · Cited by 18
Bloodworth, M. H., Newcomb, D. C., Dulek, D. E., Stier, M. T., Cephus, J. Y., Zhang, J., Goleniewska, K., Kolls, J. K., & Peebles, R. S. (2016) · Infection and Immunity · doi:10.1128/iai.00646-15 · Cited by 19
“IL-13 may regulate 17 cells indirectly, as IL-13 suppresses dendritic cell expression of 17 cell-promoting factors such as IL-1 and IL-23 (35).”
BackgroundJavan, M. R., Seyfizadeh, N., Aslani, S., Farhoodi, M., & Babaloo, Z. (2014) · Europe PMC (PubMed Central) · Cited by 20
Negative feedback on IL-23 exerted by IL-17A during pulmonary inflammation
Silverpil, E., Wright, A. K., Hansson, M., Jirholt, P., Henningsson, L., Smith, M. E., Gordon, S. B., Iwakura, Y., Gjertsson, I., Glader, P., et al. (2013) · Innate Immunity · doi:10.1177/1753425912470470 · Cited by 19
Role of Interleukin-17 family cytokines in disease severity of patients with knee osteoarthritis
Kamiab, Z., Khorramdelazad, H., Kafi, M., Jafarzadeh, A., Mohammadi-Shahrokhi, V., Bagheri‐Hosseinabadi, Z., Saeed-Askari, P., & Abbasifard, M. (2024) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-024-00351-5 · Cited by 16
“In addition, as IL-25 has been attributed to con-trol and suppress the Th17/IL-17 [15], we observed that higher levels of IL-25 was correlated with higher levels of IL-17 A.”
BackgroundInfluentialMacLean, F., Tsegaye, A. T., Graham, J. B., Swarts, J. L., Vick, S. C., Potchen, N. B., Talavera, I. C., Warrier, L., Dubrulle, J., Schroeder, L. K., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci184609 · Cited by 18
“On the other hand, LIF and IL-17E/IL-25, observed to be increased in the CVT fluid of BV + individuals (Figure 7A), inhibit inflammatory responses, including Th17-mediated immune responses (87, 88).”
Das, U. N. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01507-8 · Cited by 18
Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages
Stolfi, C., Caruso, R., Franzè, E., Sarra, M., Nitto, D. D., Rizzo, A., Pallone, F., & Monteleone, G. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03340.x · Cited by 18
Mantani, P. T., Dunér, P., Bengtsson, E., Ljungcrantz, I., Sundius, L., To, F., Nilsson, J. Å., Björkbacka, H., & Fredrikson, G. N. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000292 · Cited by 17
“Mice deficient in IL-25 were reported to suffer from severe intestinal inflammation upon helminthic infection (29) and severe experimental autoimmune encephalomyelitis (30), which in both cases was accompanied by increased Th1- and Th17-related immune responses.”
BackgroundFreitas, N. L., Deus, J. V. C., Sampaio, K., Gomes, Y. C. P., Torres, R. C., Brandão, C. O., Soares, C., Silva, M. T. T., & Espíndola, O. D. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-08632-9 · Cited by 16
“In the CNS, IL-25 helps to prevent inflammatory cell infiltration and modulates BBB repair, and regulates Th2 cytokine production, as shown in murine models 44,45 .”
Davydova, A., Kurochkina, Y. D., Goncharova, V. E., Vorobyeva, M., & Korolev, M. A. (2023) · Biomedicines · doi:10.3390/biomedicines11051328 · Cited by 16
“IL-17E (IL-25) Participation in the immune response to parasitic invasion [83–85] Anti-inflammatory effects in the colonic mucosa [86], while there is evidence of pro-inflammatory activity in the colonic mucosa [60] Anti-inflammatory activity in the central nervous system [87] Participation in the development of thymu…”
Liu, J., Zhou, X., Zhan, Z., Meng, Q., Yang, H., Shi, Q., Tang, J., Li, J., Fan, H., & Liu, Z. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.02.003 · Cited by 18
“Expression of Th17 cells in WT and IL-25 deficient mice Previous studies showed that IL-25 could suppress Th17 cells and attenuate Th17 cell mediated diseases such as EAE and Inflammatory Bowel Disease (IBD) [19,21].”
BackgroundResultInfluentialMchenga, S. S. S., da Wang, Janneh, F. M., Feng, Y., Zhang, P., Li, Z., & Lu, C. (2010) · Inflammation Research · doi:10.1007/s00011-010-0200-x · Cited by 15
The Immunogenetics of Psoriasis
Trovato, E., Rubegni, P., & Cinotti, É. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-92616-8_4 · Cited by 16
The potential roles of interleukin-25 in infectious diseases
Wu, J., Zhang, F., Tao, H., Nawaz, W., Chen, D., & Wu, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.986118 · Cited by 16
“discovered an elevated expression of TNF-a in Il-25 deficient mice, and the administration of rIL-25 suppressed IL-1b and IL-6 expression in dendritic cells in mice (55), whose suppression will expand the response of Th2 cells.”
BackgroundTang, J., Zhou, X., Liu, J., Meng, Q., Yang, H., Wang, Z., Fan, H., & Liu, Z. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.03.036 · Cited by 16
Interleukin-25 is detrimental for recovery after spinal cord injury in mice
Dooley, D., Lemmens, E., Ponsaerts, P., & Hendrix, S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0566-y · Cited by 15
“For example, IL-25 treatment suppresses Th17 responses and disease symptoms in experimental autoimmune encephalomyelitis (EAE) and is important in maintaining bloodbrain barrier function [17, 18].”
BackgroundGuan, Y., Yu, S., Zhao, Z., Ćirić, B., Zhang, G., & Rostami, A. M. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.021 · Cited by 15
“As Th17 cells and their signature cytokine IL-17 play an essential role in the pathogenesis of autoimmune diseases, in particular EAE (Chen et al., 2006; Kleinschek et al., 2007; Fitzgerald et al., 2007), suppression of Th17 function, exemplified by the inhibition of IL-17 secretion, is an important mechanism underlyi…”
BackgroundSerum cytokine profiles in myasthenia gravis with anti-muscle-specific kinase antibodies
Yasuda, M., Uzawa, A., Ozawa, Y., Kojima, Y., Onishi, Y., Akamine, H., & Kuwabara, S. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578205 · Cited by 14
Gutiérrez-Miranda, B., Gallardo, I., Melliou, E., Cabero, I., Álvarez, Y., Hernández, M., Magiatis, P., Hernández, M., & Nieto, M. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054977 · Cited by 14
Can fecal microbiota transplantations modulate autoimmune responses in type 1 diabetes?
Snethlage, C. M. F., de Wit, D. F., Wortelboer, K., Rampanelli, E., Hanssen, N. M. J., & Nieuwdorp, M. (2024) · Immunological Reviews · doi:10.1111/imr.13345 · Cited by 14
Bai, S., Su, X., Kong, D., Feng, C., Zhang, X., Pan, Y., Zhao, J., Sun, J., & Li, W. (2024) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2023-0135 · Cited by 13
“[15,16] Interactions between immune cells and airway structural cells increase the complexity of pathogenesis, asthma epigenotypes, and disease control because the treatment target is difficult to identify.”
Interleukin 17, the double-edged sword in atherosclerosis
Moeinafshar, A., Razi, S., & Rezaei, N. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152220 · Cited by 13
IL-17RA in Intestinal Inflammation: Structure, Signaling, Function, and Clinical Application
Liu, S., Ren, J., & Li, J. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000217 · Cited by 14
Interleukin-17 family in health and immune diseases: From origin to clinical implications
Deng, G., Guo, M., Fan, J., Wang, W., Jiang, M., & Zhang, C. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00026 · Cited by 14
“In the experimental autoimmune encephalomyelitis (EAE) mouse model, IL-17E expression in microglial cells of the central nervous system (CNS) increased nine-fold during disease onset, suggesting that IL-17E is crucial in modulating autoimmune disorders (Kleinschek et al., 2007).”
Lütfioğlu, M., Sakallıoğlu, U., Sakallıoğlu, E., Özden, F. O., Ürkmez, S. S., & Bilgici, B. (2021) · Journal of Periodontal Research · doi:10.1111/jre.12831 · Cited by 13
Álvarez-Izquierdo, M., Pérez-Crespo, M., Esteban, J. G., Muñoz-Antolí, C., & Toledo, R. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04467-7 · Cited by 13
Vasilev, G., Kokudeva, M., Siliogka, E., Padilla, N., Shumnalieva, R., Della‐Morte, D., Ricordi, C., Mihova, A., Infante, M., & Velikova, T. V. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i4.99936 · Cited by 12
“…IL-17 is the main effector molecule secreted by Th17 cells, an experimental study investigated whether anti-IL-17 antibodies or recombinant IL-25, which directly suppresses Th17 responses[55], could alter the natural history of diabetes in NOD mice [56], a well-established animal model of T1D[57].”
T cell transgressions: Tales of T cell form and function in diverse disease states
Harris, K. M., Clements, M. A., Kwilasz, A. J., & Watkins, L. R. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1921764 · Cited by 12
“Th2 cells release key cytokines including IL-4, IL-5, IL-9, IL-10, IL-13, IL-25, and amphiregulin.”
InfluentialLi, Y., Wang, R., Liu, S., Liu, J., Pan, W., Li, F., Ju, L., & Meng, D. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105680 · Cited by 11
Mouse Th17 cells: Current understanding of their generation and regulation
Dong, C. (2009) · European Journal of Immunology · doi:10.1002/eji.200839076 · Cited by 11
(2011) · Springer eBooks · doi:10.1007/springerreference_32754 · Cited by 11
Hashimoto, H., Kasteleiner, P., Kressin, J., Müller, F., Bühring, H., Handgretinger, R., & Schilbach, K. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01307-9 · Cited by 10
Natarajan, K., Mathialagan, G. D., Raghavan, S., & Shanmugam, N. (2015) · Cellular & Molecular Biology Letters · doi:10.1515/cmble-2015-0038 · Cited by 10
Xu, Y. Q., Ye, J., Wang, M., Liu, J., Wang, Z., Jiang, H., Ye, D., Zhang, J., & Wan, J. (2019) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2019.24265 · Cited by 13
“(45) suggested that experimental autoimmune encephalomyelitis IL-25 knockout mice presented increased levels of IL-23 in the periphery and enhanced T cells in the central nervous system, which produced IL-17, IFN-γ, and TNF.”
BackgroundAnhedonia and increased evoked immune response
Kudinova, A. Y., Gano, A., James, K. M., Lawlor, C., Deak, T., & Gibb, B. E. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100090 · Cited by 11
“T-cell-derived cytokines produced by the activated T-cells, recruit and activate different types leukocytes and induce the production of antimicrobial molecules to eliminate invading pathogens (Chang and Dong, 2009; Duvallet et al., 2011; Kleinschek et al., 2007; Rutz et al., 2013).”
BackgroundChanges and significance of IL-25 in chicken collagen II-induced experimental arthritis (CIA)
Kaiwen, W., Su, Z., Yinxia, Z., Siamak, S. S., Zhi-jun, J., Xue, Y., Yang, H., Dong, Z., Yanfang, L., Pei, S., et al. (2011) · Rheumatology International · doi:10.1007/s00296-011-1955-2 · Cited by 10
“In the course of development of EAE, IL-25 inhibits the Th17 cell diVerentiation and reduce the inXammatory response caused by IL-17 [8].”
BackgroundNouveaux acteurs dans la physiopathologie de l’asthme
Klein, M., Dijoux, E., Dilasser, F., Hassoun, D., Moui, A., Loirand, G., Colas, L., Magnan, A., Sauzeau, V., & Bouchaud, G. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.01.004 · Cited by 11
Nicola, M. D., Dasgupta, P., Nicolas, J., Svetlana, P., & Achsah, D. (2012) · InTech eBooks · doi:10.5772/25650 · Cited by 13
Pan, S., Zhang, Z., Li, C., & Dong, Y. (2020) · Cell Biology International · doi:10.1002/cbin.11430 · Cited by 9
Evaluation of the Effects of 1,25VitD3 on Inflammatory Responses and IL-25 Expression
Li, N., Saghafi, N., Ghaneifar, Z., Rezaee, S. A., Rafatpanah, H., & Abdollahi, E. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.779494 · Cited by 9
The Th17 lineage: Answers to some immunological questions
González‐García, C., Martín-Saavedra, F. M., Ballester, A., & Ballester, S. (2009) · Inmunología · doi:10.1016/s0213-9626(09)70025-3 · Cited by 12
“IL-17 and IL-23 are present in the sera, synovial fluids and synovial biopsies of RA patients(95-97).”
BackgroundInfluentialGaupp, S., Cannella, B., & Raine, C. S. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071156 · Cited by 10
“However, a lack of IL-4R in the context of EAE has not been tested in detail, evidence for its role being indirect and derived from studies on IL-4, a cytokine known to be protective during the progression of EAE(10,24) and in studies on Th17 function in EAE.(25) In the latter case, it was shown that IL-13 (which shar…”
BackgroundResultInfluentialInhibition of Proinflammatory Cytokine by IL-25 in Vogt-Koyanagi-Harada Syndrome
Xu, M., Wang, C., Tian, Y., Kijlstra, A., & Yang, P. (2013) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2013.854391 · Cited by 9
“negatively regulate Th17-mediated disorders.(21) Thus, IL-25 could potentially abrogate specific inflammatory responses and experimental models suggest that it may play a role in the pathogenesis of a number of autoimmune diseases, including inflammatory bowel diseases (IBD), multiple sclerosis, and type I diabetes (N…”
BackgroundCould IL-25 be a potential therapeutic target for intestinal inflammatory diseases?
Chen, J., Wang, Y., Shen, L., Xiu, Y., & Wang, B. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.07.001 · Cited by 9
Metadata
- Authors
- Kleinschek, M. A., Owyang, A. M., Joyce-Shaikh, B., Langrish, C. L., Chen, Y., Gorman, D. M., Blumenschein, W. M., McClanahan, T., Brombacher, F., Hurst, S. D., Kastelein, R. A., & Cua, D. J.
- Affiliations
- 1Discovery Research
- 2Experimental Pathology and Pharmacology, Schering-Plough Biopharma, Palo Alto, CA 94304
- University of Cape Town (ZA)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-01-02
- Volume
- 204
- Issue
- 1
- Pages
- 161-170
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118427
- OpenAlex
- W2118140057
- Cited by
- 396
- References
- 58
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 7 · 2023: 11 · 2022: 13 · 2021: 14 · 2020: 20 · 2019: 14 · 2018: 15 · 2017: 12 · 2016: 23 · 2015: 14 · 2014: 24 · 2013: 15 · 2012: 32
- FWCI
- 16.20
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- IL-25, Th17 cells, IL-17, autoimmune encephalomyelitis, IL-23, IL-13, dendritic cells, IL-1β, interleukin-6, IL-17 family cytokines, organ-specific autoimmunity, Th2 immune response, relapsing-remitting EAE, cytokine therapy
- MeSH terms
- Animals, Base Sequence, Central Nervous System, DNA, Encephalomyelitis, Autoimmune, Experimental, Female, T-Lymphocytes, Helper-Inducer, Inflammation, Interferon-gamma, Interleukins, Male, Mice, Inbred C57BL, Autoimmunity, Mice, Knockout, Th2 Cells, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.